PRCT-study of Different Non-operative Treatment Protocols of ER-stress Negative Weber-B Unimalleolar Ankle Fractures.
NCT ID: NCT01758835
Last Updated: 2018-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
247 participants
INTERVENTIONAL
2012-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Noninferiority RCT Comparing Operative vs Nonoperative Treatment for ER-stress Positive Weber-B Unimalleolar Fractures
NCT01758796
Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures
NCT05412693
Operative Treatment of Ankle Fractures
NCT04437355
Weight-bearing Radiographs to Evaluate Stability in Ankles With Isolated Weber Type B Fractures.
NCT03831009
Unimalleolar Versus Bimalleolar Fixation in Bi- or Trimalleolar Ankle Fracture
NCT01757951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Splint 3 weeks
Removable ankle brace/splint
Splint 3 weeks
A removable orthosis/splint. Dynacast/Ortho-Glass AS (BSN Medical). Splint is used for 3 weeks and no additional support is used after splint removal.
Cast 3 weeks
Below-the-knee cast (glass fiber)
Cast 3 weeks
A standard short boot cast from proximal tibia to MTP I-V joint line. Cast is made from 3M Scotchcast. Cast is removed after 3 weeks and no additional support is used after cast removal.
Cast 6 weeks
Below-the-knee cast (glass fiber)
Cast 6 weeks
standard short boot cast from proximal tibia to MTP I-V joint line. Cast is made from 3M Scotchcast. Cast is changed after 3 weeks and removed after 6 weeks. No additional support is used after cast removal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Splint 3 weeks
A removable orthosis/splint. Dynacast/Ortho-Glass AS (BSN Medical). Splint is used for 3 weeks and no additional support is used after splint removal.
Cast 3 weeks
A standard short boot cast from proximal tibia to MTP I-V joint line. Cast is made from 3M Scotchcast. Cast is removed after 3 weeks and no additional support is used after cast removal.
Cast 6 weeks
standard short boot cast from proximal tibia to MTP I-V joint line. Cast is made from 3M Scotchcast. Cast is changed after 3 weeks and removed after 6 weeks. No additional support is used after cast removal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ER-stress negative
* 16 or over years old
* Willingness to participate on study proved by a signature and date
* Walking without aid before accident
* Treatment started within 7 days from injury
Exclusion Criteria
* Bilateral ankle fracture
* Pathological fracture
* Diabetes mellitus or an other significant periferial neuropathy
* municipality of Residence in some else catchment area than Oulu university hospital or Tampere university hospital
* Patient's understanding or co-operation inadequate
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
University of Oulu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Harri Pakarinen
Orthopedic surgeon, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harri J Pakarinen, MD, PhD
Role: STUDY_DIRECTOR
Oulu University Hospital
Tero HJ Kortekangas, MD
Role: PRINCIPAL_INVESTIGATOR
Oulu University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OYS, kirurgian klinkka, Oulu
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kortekangas T, Haapasalo H, Flinkkila T, Ohtonen P, Nortunen S, Laine HJ, Jarvinen TL, Pakarinen H. Three week versus six week immobilisation for stable Weber B type ankle fractures: randomised, multicentre, non-inferiority clinical trial. BMJ. 2019 Jan 23;364:k5432. doi: 10.1136/bmj.k5432.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OYSrctAnkle5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.